A clinical formulation indicated for Bladder and Urinary. It supports control over bladder muscle contractions to reduce urgency and manage incontinence.
Designed to alleviate overactive bladder symptoms by addressing muscle contractions to support better bladder control and mitigate frequency of urination episodes.
Mechanism of Action
Solifenacin blocks specific receptors in the bladder muscle. By doing so, it prevents involuntary muscle contractions that cause the sudden urge to urinate, allowing the bladder to hold more urine.
Route of Administration
Oral
Onset Time
Steady state in 10 days
Duration
24 hours
Contraindications
Urinary retention, Gastric retention, Narrow-angle glaucoma, Severe liver disease
Severe Adverse Events
Angioedema, Severe constipation, Heat stroke (reduced sweating), Urinary blockage, Severe allergic reactions
Common Side Effects
Dry mouth, Constipation
Uncommon Side Effects
Blurred vision, Dry eyes, Nausea, Upset stomach
Drug Interactions
Ketoconazole, Itraconazole, Ritonavir, Other Anticholinergics
Information for Solifenacin is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
